Skip to content
10-K

Annual Report

INNOVATION PHARMACEUTICALS INC.

0001477932-23-007158

← back to feed
Filed
Sep 28, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Sep 10, 2023 514.01M sh
Operating Cash Flow FY 2023 · Jun 30, 2023 −$2.11M
Operating Cash Flow FY 2023 · Jun 30, 2022 −$6.28M
Cash And Equivalents FY 2023 · Jun 30, 2023 $1.52M
Cash And Equivalents FY 2023 · Jun 30, 2022 $3.81M
Stockholders Equity FY 2023 · Jun 30, 2023 $2.04M
Stockholders Equity FY 2023 · Jun 30, 2022 $4.73M
Stockholders Equity FY 2023 · Jun 30, 2021 $7.51M
Current Liabilities FY 2023 · Jun 30, 2023 $5.02M
Current Liabilities FY 2023 · Jun 30, 2022 $4.81M
Total Liabilities FY 2023 · Jun 30, 2023 $5.48M
Total Liabilities FY 2023 · Jun 30, 2022 $5.65M
Current Assets FY 2023 · Jun 30, 2023 $1.63M
Current Assets FY 2023 · Jun 30, 2022 $3.95M
Total Assets FY 2023 · Jun 30, 2023 $7.52M
Total Assets FY 2023 · Jun 30, 2022 $10.38M
Sga Expense FY 2023 · Jun 30, 2023 $750K
Sga Expense FY 2023 · Jun 30, 2022 $1.22M
Rd Expense FY 2023 · Jun 30, 2023 $1.46M
Rd Expense FY 2023 · Jun 30, 2022 $4.81M
Net Income FY 2023 · Jun 30, 2023 −$3.17M
Net Income FY 2023 · Jun 30, 2022 −$7.04M
Operating Income FY 2023 · Jun 30, 2023 −$3.11M
Operating Income FY 2023 · Jun 30, 2022 −$6.92M
Revenue FY 2023 · Jun 30, 2023 $0
Revenue FY 2023 · Jun 30, 2022 $18K